Nutex Health (US:NUTX) Globenewswireยท2025-10-13 02:33Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on October 21, 2025, for a class action lawsuit [1][2] Group 1: Class Action Details - Investors who bought Nutex securities between August 8, 2024, and August 14, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2] - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] Group 2: Case Allegations - The lawsuit alleges that Nutex made false and misleading statements regarding its financial practices and internal controls, particularly concerning its relationship with HaloMD, a third-party vendor [4] - Specific claims include that Nutex's revenues from HaloMD were unsustainable due to fraudulent conduct, and that the company overstated its ability to remediate weaknesses in its financial reporting [4] - The allegations suggest that Nutex improperly classified stock-based compensation obligations, which increased the risk of failing to file timely financial reports with the SEC [4]